Taysha Gene Therapies (TSHA) PT Raised to $10 at BMO Capital
Tweet
Share
E-mailGet Alerts TSHA Hot Sheet
Price: $5.71 +2.33%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
BMO Capital analyst Evan Seigerman raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $10.00 (from $8.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- Rackspace Technology Inc. (RXT) PT Raised to $5.50 at UBS
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$231 at Bernstein SocGen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
